Venous Involvement in Takayasu Disease: A Case Report
Published: 2022-12-24
Page: 247-253
Issue: 2022 - Volume 4 [Issue 1]
Meriem El Mousaid *
Département de Cardiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
Essadqi Fadwa
Département de Cardiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
Asmaa Elamraoui
Département de Cardiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
Keltoum Boumlik
Département de Radiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
Rachida Habbal
Département de Cardiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Takayasu's disease (TD) is an inflammatory arteritis of the large vessels that affects with predilection the aorta and its main branches, the thickening of the vascular wall is the most characteristic early sign of the disease leading progressively to stenoses, thromboses and occasionally the development of aneurysms. It is a vasculitis that generally spares the veins, few cases of deep vein thrombosis (DVT) have been reported during this pathology. It is in this order that we report the case of a 48-year-old patient followed for a month in the internal medicine department for Takayasu's disease, a diagnosis established because of her young age, female gender, abolition of pulses in the lower limbs and the radiological aspect. The patient underwent treatment with high-dose corticosteroid therapy (prednisone 1 mg/kg per day). For DVT, she was put on DOAC. The evolution under treatment was marked by the regression of the inflammatory signs and the negativation of the infectious assessment. Addressing this issue is important as the risk of restenosis or occlusion is still high with vascular interventions.
Keywords: Takayasu disease, deep vein thrombosis, vasculitis, aorta
How to Cite
Downloads
References
Saadoun D, Bura-Riviere A, Comarmond C, Lambert M, Redheuil A, Mirault T. French recommendations for the management of Takayasu’s arteritis. Orphanet Journal of Rare Diseases. 2021; 16(3):1-23.
Nesher G, Ben-Chetrit E, Mazal B, Breuer GS. The incidence of primary systemic vasculitis in Jerusalem: A 20-year hospital-based retrospective study. J Rheumatol. 2016;43:1072–1077. This is an epidemiologic survey that examined the incidence rates of primary systemic vasculitides in the Jewish population of Jerusalem from Israel. Trends in incidence rates over a 20-year period were also examined.
Yoshida M, Watanabe R, Ishii T, et al. Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience. Int J Rheum Dis 2016;19:87–94. This study investigates the clinical differences between 86 patients with Takayasu arteritis and nine patients with GCA followed by a single center in Tohoku Region, Japan from 1990 to 2014.
Kermani TA, Crowson CS, Muratore F, et al. Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they? Semin Arthritis Rheum. 2015;44:724–728.
Alibaz-Oner F, Aydin SZ, Akar S, et al. Assessment of patients with Takayasu arteritis in routine practice with Indian Takayasu Clinical Activity Score. J Rheumatol 2015;42:1443–1447. A multicenter controlled study that compares two outcome measures.
Alibaz-Oner F, Direskeneli H. Update on Takayasu’s arteritis. Presse Med 2015;44(Pt 2):e259–e265. This is a comprehensive review and summary of the recent developments in Takayasu arteritis.
Kato Y, Terashima M, Ohigashi H, et al. Vessel wall inflammation of Takayasu arteritis detected by contrast-enhanced magnetic resonance imaging: Association with disease distribution and activity. PLoS One. 2015;10:e0145855.